C.difficile

3 stories · following the connections

Business

Immuron Commences US Non-Deal Institutional Investor Roadshow

By Nasdaq OMXAug 15, 2017, 1:15 PM UTC

Business

Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)

By Nasdaq OMXAug 9, 2017, 12:30 PM UTC

Business

HiberGene Launches HG C. Difficile Test

By Nasdaq OMXDec 15, 2016, 9:56 AM UTC